Logo image
Three-dimensional conformal fractionated radiotherapy for spinal schwannoma with a paravertebral or an intraosseous component
期刊文章   同儕審查

Three-dimensional conformal fractionated radiotherapy for spinal schwannoma with a paravertebral or an intraosseous component

Rikiya Onimaru, Kazutoshi Hida, Naoki Takeda, Shunsuke Onodera, Yukiko Nishikawa, Takashi Mori, Hiroki Shirato 和 Fang-Hsin Chen
Japanese journal of radiology, 卷.33(12), 頁碼.757-763
01/12/2015
PMID: 26507984
Web of Science ID: WOS:000367539800005

摘要

Adolescent Adult Aged Child Dose Fractionation Female Follow-Up Studies Humans Imaging, Three-Dimensional Male Middle Aged Neurilemmoma - diagnostic imaging Neurilemmoma - radiotherapy Radiotherapy, Conformal - methods Retrospective Studies Spinal Neoplasms - diagnostic imaging Spinal Neoplasms - radiotherapy Spine - diagnostic imaging Tomography, X-Ray Computed Treatment Outcome Young Adult
We retrospectively evaluated the efficacy of three-dimensional conformal radiotherapy (3D-CRT) for spinal schwannoma. Nine patients with spinal schwannoma were treated with 3D-CRT. All patients had a paravertebral or intraosseous component. Tumor sizes ranged from 0.8 to 8.7 cm, with a median of 3.5 cm. The prescribed dose was 50 Gy in 25 fractions at the isocenter, except for 1 patient who received 66 Gy in 33 fractions for a large sacral tumor. The follow-up period ranged from 20 to 137 months, with a median of 72 months. Tumor shrinkage within 3 mm occurred in 4 patients and tumor expansion within 3 mm occurred in 3. One tumor showed neither expansion nor shrinkage at the last follow-up. One patient experienced transient expansion by 8 mm in diameter at 12 months after the completion of radiotherapy (35-43 mm), and then the tumor size remained unchanged for 7 years. No severe late toxicity ≥ grade 3 was observed. Only 1 of 9 tumors showed transit expansion over 3 mm after 3D-CRT, and severe late radiation toxicity was not observed. Use of 3D-CRT should be considered a treatment option for spinal schwannoma.

相關連結

詳細資料

Logo image